盐诱导酶3与抑制剂复合的结构揭示了结合和选择性的决定因素
Linda Öster1, Marie Castaldo2, Emma de Vries3
1Mechanistic and Structural Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden.
The Journal of biological chemistry
|March 20, 2024
概括
盐诱导酶 (SIK) 是生理过程的关键调节者和药物标. 我们解决了SIK3结构,揭示了其活性构造,并使选择性抑制剂的基于结构的药物设计成为可能.
科学领域:
- 生物化学和结构生物学
- 药理学 药理学是指药理学的学科.
- 分子医学是分子医学.
背景情况:
- 盐诱导激酶 (SIKs) 1-3调节新陈代谢,免疫力和心脏功能.
- SIKs是药理干预各种疾病的关键目标.
- 实验性SIK激酶结构的稀缺性阻碍了药物开发.
研究的目的:
- 为了获得SIK3的高分辨率结构,与抑制剂复合.
- 为了促进选择性SIK抑制剂的基于结构的药物设计.
- 了解SIK3活性构成和抑制剂相互作用.
主要方法:
- 合理的蛋白质结构设计和净化.
- 对SIK3抑制剂复合物的X射线晶体学.
- 鉴定抗体片段以帮助结晶.
主要成果:
- 通过抑制剂HG-9-91-01.1.成功结晶并解决了SIK3的结构.
- 揭示了SIK3的活性构造,其由其无素相关域稳定.
- 介绍了四种不同的SIK3抑制剂复合物,详细介绍了配体相互作用和ATP位点参与.
- 提供了对SIK3异形选择性通过特定抑制剂复合物的洞察力.
结论:
- 解决的SIK3结构为基于结构的药物设计提供了基础.
- 开发的结晶协议使得进一步的SIK3抑制剂复合体研究成为可能.
- 了解SIK3抑制剂相互作用可以指导选择性治疗的发展.
相关概念视频
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
Eukaryotic Transcription Inhibitors
9.8K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K
Enzymes
81.5K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
81.5K
Enzyme Inhibition
78.3K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.3K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K


